Sugi Predict

Sugi Predict / Compounds / SCHEMBL5847495

SCHEMBL5847495

SCHEMBL5847495

CCc1nn2ccccc2c1NC(=O)C1CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ MMP3 P08254 1/20 0.42
▸ MMP12 P39900 1/20 0.42
▸ JAK1 P23458 1/20 0.41
▸ ABL1 P00519 2/20 0.40
▸ HPGD P15428 2/20 0.39
▸ LMNA P02545 2/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ TDP1 Q9NUW8 2/20 0.39
▸ HDAC1 Q13547 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ MTNR1A P48039 1/20 0.38
▸ MTNR1B P49286 1/20 0.38
▸ TP53 P04637 2/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ KLF5 Q13887 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4035512 0.93 MMP12 (0.47) ALDH1A1SMN1; SMN2MMP3MMP12JAK1
SCHEMBL4040645 0.84 HDAC1 (0.43) ALDH1A1SMN1; SMN2MMP3MMP12ABL1
SCHEMBL5847931 0.83 MAP4K4 (0.47) ALDH1A1SMN1; SMN2MMP3MMP12ABL1
SCHEMBL5848211 0.78 TSHR (0.42) ALDH1A1SMN1; SMN2HPGDMEN1KMT2A
SCHEMBL4035121 0.77 BRD4 (0.39) ALDH1A1SMN1; SMN2MEN1KMT2AHDAC1
SCHEMBL5848998 0.73 HTT (0.39) ALDH1A1MMP3MMP12HPGDLMNA
SCHEMBL683926 0.72 MIF (0.50) ALDH1A1SMN1; SMN2MMP3MMP12HPGD
SCHEMBL5847816 0.71 DRD2 (0.42) MMP3MMP12MEN1KMT2AHDAC1
SCHEMBL4034627 0.71 MMP3 (0.41) MMP3MMP12HDAC1
Hydrochloric Acid SCHEMBL4035325 0.70 KCNH3 (0.42) MMP3MMP12HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7151109-B2 Pyrazolo[1,5-a]pyridine derivatives and their use as neurotransmitter modulators PHARMACIA & UPJOHN COMPANY LLC (US) 2006-12-19 — — US disclosed
EP-1485384-A1 PYRAZOLO(1,5-A)PYRIDINE DERIVATIVES AS NEUROTRANSMITTER MODULATORS Pharmacia & Upjohn Company LLC (US) 2004-12-15 — — EP disclosed
EP-1438314-A1 A PROCESS FOR PREPARING ENANTIOMERICALLY PURE ALPHA-PHENYL-APLPHA(6,7-DIHYDRO-4H-THIENO 3,2-C PYRIDIN-5-YL)-ACETIC ACID DERIVATIVES Merck Generics (UK) Limited (GB) 2004-07-21 — — EP disclosed
US-20040002511-A1 Novel pyrazolo[1,5-a]pyridine derivatives and their use as neurotransmitter modulators PHARMACIA & UPJOHN COMPANY 2004-01-01 — — US disclosed
WO-2003078435-A1 PYRAZOLO(1,5-A)PYRIDINE DERIVATIVES AS NEUROTRANSMITTER MODULATORS PHARMACIA & UPJOHN COMPANY LLC (US) 2003-09-25 — — WO disclosed
WO-2003035652-A1 A PROCESS FOR PREPARING ENANTIOMERICALLY PURE α-PHENYL-α-(6,7-DIHYDRO-4H-THIENO[3,2-C]PYRIDIN-5-YL)-ACETIC ACID DERIVATIVES MERCK GENERICS [UK] LIMITED (GB) 2003-05-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040002511-A1 Novel pyrazolo[1,5-a]pyridine derivatives and their use as neurotransmitter modulators CRHR1, HTR5A, CRH ALDH1A1 911/4885SMN1; SMN2 3430/4885MMP3 4691/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.